Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director · Chief Executive Officer | October 08, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date October 08, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,531,999 |
Reported balance
After 2026-10-08 transaction · row 1
1 source rowRow 1 · 2026-10-08 · Tax withholding · Disposed 29,250 · Balance 1,531,999 F1: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. |
| Class A Common StockSEC Table I · non-derivative | IndirectThe Bernd Brust Management Trust | 466,771 |
Reported balance
Holding disclosure · report date 2026-10-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 466,771 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2026 Filed Oct 9, 2026 21:51 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 29,250 | $7.43 | $217,327.50 |
DisclosureSEC source: 0001380632-26-000010 · wk-form4_1791582694.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531,999 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 22:49 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 29,250 | $7.32 | $214,110.00 |
DisclosureSEC source: 0001380632-26-000008 · wk-form4_1788994162.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,561,249 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 20:44 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 29,250 | $6.23 | $182,227.50 |
DisclosureSEC source: 0001380632-26-000006 · wk-form4_1786481056.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590,499 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 21:34 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 29,250 | $5.92 | $173,160.00 |
DisclosureSEC source: 0001380632-26-000004 · wk-form4_1783719267.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,619,749 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:07 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 351,001 | $5.02 | $1,762,025.02 |
DisclosureSEC source: 0001380632-26-000002 · wk-form4_1781125627.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,648,999 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 21:48 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 216,212 | $3.25 | $702,689.00 |
DisclosureSEC source: 0001380632-25-000006 · wk-form4_1763416092.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Bernd Brust Management Trust Disclosed balance after: 466,771 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.235 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 22:27 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 93,358 | $3.21 | $299,679.18 |
DisclosureSEC source: 0001380632-25-000004 · wk-form4_1763072862.xml · nonDerivative · entry 2 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Bernd Brust Management Trust Disclosed balance after: 250,559 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.175 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:27 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 157,201 | $3.24 | $509,331.24 |
DisclosureSEC source: 0001380632-25-000004 · wk-form4_1763072862.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · The Bernd Brust Management Trust Disclosed balance after: 157,201 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.18 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 21:29 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantPerformance Stock Units · Derivative | 2,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-084483 · ownership.xml · derivative · entry 3 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250,000 Underlying: Class A Common Stock · 2,250,000 shares Expires 2028-07-08 F3 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") awarded under the Omnibus Incentive Plan. Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest if and to the extent the volume-weighted average price of a share of the Class A Common Stock of the Issuer equals or exceeds certain thresholds for the 30 consecutive trading days immediately preceding the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer (except as otherwise provided in connection with certain circumstances as set forth in the award agreement). F3 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") awarded under the Omnibus Incentive Plan. Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest if and to the extent the volume-weighted average price of a share of the Class A Common Stock of the Issuer equals or exceeds certain thresholds for the 30 consecutive trading days immediately preceding the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer (except as otherwise provided in connection with certain circumstances as set forth in the award agreement). Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 21:29 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0000950170-25-084483 · ownership.xml · derivative · entry 2 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires 2035-06-08 F2 · derivative.exercise_date: Represents options awarded under the Omnibus Incentive Plan. These options vest over a three-year period, with one-third of the options vesting on the first anniversary of the grant date and the remaining two-thirds of the options vesting in 24 substantially equal monthly installments, subject to the Reporting Person's continued employment with the Issuer (except as otherwise provided in connection with certain circumstances as set forth in the award agreement). Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 21:29 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 2,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-084483 · ownership.xml · nonDerivative · entry 1 Brust Bernd · CIK 0001380632 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs vest over a three-year period, with one-third of the RSUs vesting on the first anniversary of the grant date and the remaining two-thirds of the RSUs vesting in 24 substantially equal monthly installments, subject to the Reporting Person's continued employment with the Issuer (except as otherwise provided in connection with certain circumstances as set forth in the award agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.